As of May 24, 2025, Liquidia Corp (LQDA) reports a Gross Margin of 58.00%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Liquidia Corp's Gross Margin
Over recent years, Liquidia Corp's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 58.00% |
| 2023-12-31 | 83.49% |
| 2022-12-31 | 82.06% |
| 2021-12-31 | 76.50% |
| 2020-12-31 | 67.57% |
This fluctuation highlights how Liquidia Corp manages its operational efficiency and pricing power over time.
Comparing Liquidia Corp's Gross Margin to Peers
To better understand Liquidia Corp's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Liquidia Corp (LQDA) | 58.00% |
| Graybug Vision Inc (GRAY) | 7775.20% |
| Akari Therapeutics PLC (AKTX) | 7775.20% |
| Royalty Pharma PLC (RPRX) | 7775.20% |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 7775.20% |
| Lipocine Inc (LPCN) | 7775.20% |
Compared to its competitors, Liquidia Corp's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.